Xeomin available for cervical dystonia and blepharospasm

Merz Pharmaceuticals has launched Xeomin (incobotulinumtoxinA) for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck pain in both botulinum toxin-naïve and previously treated patients and blepharospasm in adults previously treated with onabotulinumtoxinA. Xeomin is a botulinum toxin type A that is free from accessory proteins.

Xeomin is available in 50-unit and 100-unit vials.

For more information call (888) 4-XEOMIN or visit www.xeomin.com.